Ligand Pharmaceuticals
LGND
#3463
Rank
โ‚ฌ3.37 B
Marketcap
169,47ย โ‚ฌ
Share price
-4.03%
Change (1 day)
70.44%
Change (1 year)

Ligand Pharmaceuticals (LGND) - Total assets

Total assets on the balance sheet as of December 2025 : โ‚ฌ1.35 Billion

According to Ligand Pharmaceuticals's latest financial reports the company's total assets are โ‚ฌ1.35 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Ligand Pharmaceuticals - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2025-12-31โ‚ฌ1.32 B46.79%
2024-12-31โ‚ฌ0.90 B27.09%
2023-12-31โ‚ฌ0.71 B0.16%
2022-12-31โ‚ฌ0.71 B-37.95%
2021-12-31โ‚ฌ1.14 B3.45%
2020-12-31โ‚ฌ1.10 B-17%
2019-12-31โ‚ฌ1.33 B21.08%
2018-12-31โ‚ฌ1.10 B97.07%
2017-12-31โ‚ฌ0.55 B-2.22%
2016-12-31โ‚ฌ0.57 B24.31%
2015-12-31โ‚ฌ0.46 B116.86%
2014-12-31โ‚ฌ0.21 B179.81%
2013-12-31โ‚ฌ75.82 M-3.8%
2012-12-31โ‚ฌ78.81 M-15.11%
2011-12-31โ‚ฌ92.85 M63.46%
2010-12-31โ‚ฌ56.8 M-42.61%
2009-12-31โ‚ฌ98.97 M-19.29%
2008-12-31โ‚ฌ0.12 B3.34%
2007-12-31โ‚ฌ0.11 B-51.97%
2006-12-31โ‚ฌ0.24 B-6.96%
2005-12-31โ‚ฌ0.26 B8.36%
2004-12-31โ‚ฌ0.24 B-1.74%
2003-12-31โ‚ฌ0.24 B-5.33%
2002-12-31โ‚ฌ0.26 B98.08%
2001-12-31โ‚ฌ0.13 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ172.69 B 12,664.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ180.45 B 13,238.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ97.50 B 7,107.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ78.53 B 5,704.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
โ‚ฌ17.38 B 1,185.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ118.65 B 8,669.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ78.05 B 5,669.30%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚ฌ71.35 B 5,174.04%๐Ÿ‡ฌ๐Ÿ‡ง UK
Spectrum Pharmaceuticals
SPPI
โ‚ฌ93.34 M-93.10%๐Ÿ‡บ๐Ÿ‡ธ USA